Eliana Clark, the EVP of $NTLA, sold 1,022 shares of the company on 07-01-2025 for an estimated $10,036. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.1% of their shares of this class of stock. Following this trade, they now own 95,369 shares of this class of $NTLA stock.
$NTLA Insider Trading Activity
$NTLA insiders have traded $NTLA stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $NTLA stock by insiders over the last 6 months:
- JOHN M LEONARD (President and CEO) sold 26,807 shares for an estimated $326,509
- DAVID LEBWOHL (EVP, Chief Medical Officer) sold 9,557 shares for an estimated $116,404
- LAURA SEPP-LORENZINO (EVP, Chief Scientific Officer) sold 8,966 shares for an estimated $109,205
- JAMES BASTA (EVP, General Counsel) sold 7,074 shares for an estimated $86,161
- DEREK HICKS (EVP, Chief Business Officer) sold 6,502 shares for an estimated $79,194
- MICHAEL P DUBE (VP, Chief Accounting Officer) has made 0 purchases and 2 sales selling 3,875 shares for an estimated $41,615.
- JESSE GOODMAN has made 0 purchases and 2 sales selling 3,094 shares for an estimated $29,068.
- ELIANA CLARK (EVP, Chief Technical Officer) has made 0 purchases and 2 sales selling 1,701 shares for an estimated $16,140.
- MUNA BHANJI has made 0 purchases and 2 sales selling 530 shares for an estimated $4,894.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NTLA Hedge Fund Activity
We have seen 133 institutional investors add shares of $NTLA stock to their portfolio, and 142 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL INTERNATIONAL INVESTORS added 3,779,424 shares (+inf%) to their portfolio in Q1 2025, for an estimated $26,871,704
- CONTRARIUS GROUP HOLDINGS LTD added 1,009,177 shares (+99.7%) to their portfolio in Q1 2025, for an estimated $7,175,248
- BALYASNY ASSET MANAGEMENT L.P. removed 791,209 shares (-34.3%) from their portfolio in Q1 2025, for an estimated $5,625,495
- WELLINGTON MANAGEMENT GROUP LLP removed 699,814 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $4,975,677
- STATE STREET CORP removed 695,437 shares (-13.4%) from their portfolio in Q1 2025, for an estimated $4,944,557
- UBS GROUP AG removed 614,964 shares (-35.3%) from their portfolio in Q1 2025, for an estimated $4,372,394
- VANGUARD GROUP INC added 561,978 shares (+5.5%) to their portfolio in Q1 2025, for an estimated $3,995,663
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NTLA Analyst Ratings
Wall Street analysts have issued reports on $NTLA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- H.C. Wainwright issued a "Buy" rating on 03/05/2025
To track analyst ratings and price targets for $NTLA, check out Quiver Quantitative's $NTLA forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
